Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.51 EUR | +1.49% | -10.07% | +154.24% |
14/05 | WDH/Survey: Seven percent of adults have bought cannabis seeds | DP |
09/05 | Medical Cannabis Group SynBiotic Buys Local Peer Weeco Pharma | MT |
Sales 2021 | 9.06 8.44 756.16 | Sales 2022 | 8.17 7.61 681.23 | Capitalization | 37.92M 35.31M 3.16B |
---|---|---|---|---|---|
Net income 2021 | -12M -11.18M -1B | Net income 2022 | -24M -22.35M -2B | EV / Sales 2021 | 1,07,83,962 x |
Net Debt 2021 | 215K 200K 17.91M | Net Debt 2022 | 3.17M 2.95M 264M | EV / Sales 2022 | 50,31,340 x |
P/E ratio 2021 |
-7.04
x | P/E ratio 2022 |
-1.73
x | Employees | 104 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 100% |
1 day | +1.49% | ||
1 week | -10.07% | ||
Current month | -8.54% | ||
1 month | -17.40% | ||
3 months | -41.63% | ||
6 months | +155.10% | ||
Current year | +154.24% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Kruse
CEO | Chief Executive Officer | - | 21/23/21 |
Rebecca Kruse
DFI | Director of Finance/CFO | - | 01/23/01 |
Thomas Haffner
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Frank Otto
BRD | Director/Board Member | - | - |
Date | Price | Change | Volume |
---|---|---|---|
24/24/24 | 7.5 | +1.35% | 1 377 |
21/24/21 | 7.4 | -4.64% | 7,012 |
20/24/20 | 7.76 | -3.72% | 8,078 |
19/24/19 | 8.06 | +1.00% | 2,764 |
18/24/18 | 7.98 | -4.32% | 10,277 |
Delayed Quote Xetra, June 24, 2024 at 06:08 pm IST
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+86.13% | 1.74B | |
+100.00% | 67.46M | |
+263.64% | 50.08M |
- Stock Market
- Equities
- SBX Stock
- SBX Stock